3-bromopyruvate induces morphological alteration and may initiate programmed cell death in Cryptococcus neoformans

Katarzyna Przywara1, Ryszard Adamski2, Marta Książczyk3

  • 1Department of Mycology and Genetics, Faculty of Biological Sciences, University of Wrocław, Wrocław, Poland. katarzyna.przywara@uwr.edu.pl.

PubMed

Insights

3-Bromopyruvate (3BP) effectively targets the fungus Cryptococcus neoformans by disrupting cellular energy and glutathione levels. This study reveals 3BP induces fungal cell death via a mitochondrial pathway, suggesting its therapeutic potential.

Area of Science:

  • Medical Mycology
  • Biochemistry
  • Cell Biology

Background:

  • 3-Bromopyruvate (3BP) demonstrates anticancer properties and antifungal activity against Cryptococcus neoformans.
  • Previous research indicates 3BP's fungicidal action stems from ATP depletion and reduced intracellular glutathione.
  • Further investigation into 3BP's precise mechanisms against C. neoformans is warranted.

Purpose of the Study:

  • To elucidate the detailed mechanisms by which 3-Bromopyruvate exerts its fungicidal effects on Cryptococcus neoformans.
  • To explore the role of mitochondrial pathways and cellular responses in 3BP-induced fungal cell death.

Main Methods:

  • Flow cytometry was employed to assess fungal survival rates under 3BP treatment.
  • Electron microscopy was utilized to observe alterations in C. neoformans cellular morphology.
  • Ruthenium red staining, free radical generation analysis, and gene expression profiling were performed to investigate cellular pathways.

Main Results:

  • 3BP treatment led to significant changes in C. neoformans cell morphology and survival.
  • Evidence suggests that 3BP initiates programmed cell death through a mitochondrial pathway.
  • Analysis indicated increased free radical generation and altered gene expression patterns consistent with mitochondrial dysfunction.

Conclusions:

  • 3-Bromopyruvate induces cell death in Cryptococcus neoformans via a mitochondrial-mediated programmed cell death pathway.
  • The findings provide a deeper understanding of 3BP's antifungal mechanisms.
  • 3BP shows promise as a potential therapeutic agent for treating cryptococcosis.